Since 1980, 11 examples of cardiac tumour have been detected in the fetus out ofa total of 794 congenital cardiac malformations. Patients were referred because of fetal hydrops in two, a family history oftuberous sclerosis in two, and because of the detection of a tumour mass during a scan at the local hospital in seven. The gestational age range at presentation was from 20-34 weeks. Of eight fetuses where death occurred, the histological type was rhabdomyoma in seven and teratoma in one. In seven cases, the lesion appeared single and in four there were multiple tumours. In two ofthe cases ofrhabdomyoma, other family members had evidence oftuberous sclerosis. Termination ofpregnancy took place in four cases; of seven continuing pregnancies, spontaneous intrauterine death occurred in four, and three children are still alive. Two of the three survivors has the clinical picture of tuberous sclerosis. The last case is as yet only 1 month old.
Cardiac tumours are rare in infants and children and are reported in 0-08% ofchildren presenting to a paediatric cardiac referral centrel and between 0.0017% and 0-25% of a necropsy series.2 3 Of 444 primary tumours reported by McAllister and Fenoglio, the most frequent histological type was rhabdomyoma, occurring up to three times more frequently than teratoma and fibroma in infants. Myxomas were found rarely in children but not seen in infants. The first case reports of the detection of a cardiac tumour in prenatal life were published in 1983, using M mode and cross sectional echocardiography, to diagnose a teratoma and a rhabdomyoma respectively.4 5 Since then several case reports have appeared in the literature.68 Since 1980 we have seen 1 1 examples of cardiac tumours in fetal life. We have studied the presentation, the type, and outcome of these cases.
Subjects and methods From a series of over 10 000 fetal scans, heart disease was detected prenatally in 794. Of these, 1 1 fetuses had cardiac tumours. Intrapulmonary tumours were also found but differentiated from cardiac tumours by their position outside the pericardial cavity. Two fetuses were referred because of the detection of fetal hydrops, and two because of a family history of tuberous sclerosis. The remaining seven patients were referred because the tumour was suspected at the local hospital scan. In two patients, the diagnosis was made by sending a videotape of the scan recorded at the referral hospital. Patients were scanned using an Advanced Technical Laboratories Mark 3 or latterly Mark 4, and/or a Hewlett Packard 77020A phased array with colour flow mapping facility. Each videotape recording was examined retrospectively. The following features were noted: the presence ofhydrops fetalis; the morphology and characteristics of the tumour; whether it was single or multiple; the position, and the presence or potential for obstruction to intracardiac flow. In four patients, successive examinations were performed during pregnancy. Any change in tumour characteristics were recorded. The outcome of each pregnancy was determined. In the eight fetuses in whom postmortem examination took place, the characteristics of the tumour were compared with the echocardiographic findings and histology obtained. The clinical findings in the three survivors were obtained.
Results
In one case, scanned initially at 18 weeks' gestation for a family history of cardiac tumour, a normal scan was found. On rescan at 22 weeks' gestation, tumours were clearly seen. Two fetuses were hydropic on referral and two 10 Structural heart disease has been described in previous cases. 1 15 Of the two other cases ofrhabdomyoma studied sequentially, the tumours increased in size in one and remained the same in the other. There is no evidence of regression during intrauterine life and maternal hormones have been implicated in their development and in postnatal regression. The teratoma increased strikingly in size between 20 weeks and intrauterine death at 30 weeks' gestation. The echocardiographic appearance of the cystic nature of this tumour and its epicardial position were characteristic of teratoma and contrasted with the appearance ofthe more commonly occurring rhabdomyomas, none of which were cystic and all of which were intracardiac. The tumours in all our surviving cases have regressed in postnatal life, which is consistent with previous reports.8 16 The histological findings are consistent with previous reports and with the findings in children, in that rhabdomyoma was much the most common histological type of tumour. Rhabdomyomas are associated with tuberous sclerosis in between 50% and 78% ofcases, according to different authors.1 8 In none of the fetal necropsy specimens was evidence of tuberous sclerosis found elsewhere in the fetus despite the presence ofproved tuberous sclerosis in one parent in each of two cases. Of the three surviving neonates, one developed the clinical features of tuberous sclerosis at 6 months of age and the second at almost 1 year of age. The remaining neonate is only 1 month old at present but we feel is highly likely to develop the picture of tuberous sclerosis in later infancy. This would suggest that apart from rhabdomyoma, the other signs oftuberous sclerosis are rarely found in fetal life or early infancy, although this will be the underlying diagnosis eventually.
The severity of the clinical picture, particularly offits and developmental delay, although usually associated with significant handicap, can be variable.One of our affected parents had never had fits and was of normal intelligence. Similarly, family studies in cases of children with tuberous sclerosis have revealed unsuspected affected parents.6 1718 A family history of tuberous sclerosis is an unusual cause of referral to our unit. A total of five patients have been referred for this reason in 11 years, including the two which proved positive. Part ofthe explanation for this may be that the absence of cardiac tumours in the fetus does not guarantee absence of the disease. Geva et al suggested that intrauterine surgery for an obstructive cardiac rhabdomyoma might be beneficial and that a normal necropsy excludes tuberous sclerosis. 13 Our results indicate that this is not so and we do not feel that such treatment should be offered.
Despite the location ofthe gene for tuberous sclerosis on chromosome 9, multiple loci are suspected and diagnosis by gene mapping is not yet available. In view of this, and the spontaneous mutation rate of at least 60%/,19 echocardiographic examination of the high risk pregnancy for cardiac tumours may be the only method of detecting an affected fetus in the immediate future. However, the absence of cardiac tumours in a high risk fetus will not exclude the diagnosis of tuberous sclerosis.
